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The human mitochondrial transcription ter-
mination factor mTERF plays a central role
in the control of heavy-strand rDNA tran-
scription by promoting initiation, besides
termination, of this transcription. However,
until now, the mechanism underlying this
stimulation of transcription by mTERF was
not understood. In the present work, addi-
tion of mTERF to a HeLa cell mitochondrial
lysate-based reaction mixture containing
an artificial rDNA template did indeed spe-
cifically stimulate rDNA transcription. This
stimulation required that mTERF be simul-
taneously bound to the rDNA transcription
termination and initiation sites in the same
molecule, thus forming a loop. Most sig-
nificantly, a double binding of mTERF to
the rDNA molecule, with resulting loop for-
mation, was also shown in vivo. These re-
sults strongly suggest that, to satisfy the
need for high rate of rDNA transcription,
human mitochondrial rRNA synthesis in-
volves mTERF-mediated rDNA looping that
promotes recycling of the transcription
machinery.
INTRODUCTION
According to evidence that we obtained about 25 years ago
(Montoya et al., 1982, 1983), transcription of the HeLa cell
mtDNA heavy (H) strand (rich in guanine [Vinograd et al.,
1963]) starts from two initiation sites within the main control
region (Figures 1A and 2C). One site (H1) is situated 16 bp
upstream of the tRNAPhe gene and produces a transcriptCellwhich terminates at the 30 end of the 16S rRNA gene and
is destined to be processed, yielding the two rRNAs, the
tRNAPhe and the tRNAVal. The second site (H2) is near the
50 end of the 12S rRNA gene and produces a polycistronic
molecule, which corresponds to almost the entire H strand
and is processed to yield the mRNAs and most of the tRNAs
encoded in the H strand. Subsequently, we showed that ter-
mination of transcription at the boundary between the 30 end
of the 16S rRNA gene and the tRNALeu(UUR) genes is medi-
ated by a termination factor, mTERF (Kruse et al., 1989; Fer-
na´ndez-Silva et al., 1997). This factor is a 342 residue DNA
binding protein that carries three leucine zippers, of which
one is bipartite, and two widely spaced basic domains. This
factor was previously shown to bind to a 28 base pair region
within the tRNALeu(UUR) gene, at a position immediately adja-
cent to the 16S rRNA gene.
The rate of synthesis of rRNA is 15- to 60-fold higher
relative to mRNA (Montoya et al., 1982, 1983). A striking ob-
servation in the analysis of mTERF (Kruse et al., 1989; Asin-
Cayuela et al., 2004) was that, in an in vitro transcription sys-
tem, mTERF stimulates transcription of mitochondrial rDNA,
starting from its natural starting site (H1). However, the fact
that this stimulation by mTERF was not observed when tem-
plate DNAs containing a nonnatural starting site were used,
even with a natural termination site (Hess et al., 1991; Prieto-
Martı´n et al., 2004), suggested that mTERF interaction with
both the natural termination and H1 initiation sites may be
essential for this specific stimulation effect. In the present
work, we demonstrate incontrovertibly the requirement, to
achieve this stimulation, of a double DNA binding by mTERF,
which causes a specific looping-out of the rDNA.
RESULTS
The Two Initiation Sites H1 and H2 for In Vivo mtDNA
H Strand Transcription
First, we confirmed the precise identification and mapping
of the two sites of human mtDNA H strand transcription ini-
tiation, H1 and H2, discovered earlier in HeLa cells (Montoya
et al., 1982, 1983) by two approaches. One involved 50 end
labeling of the in vivo HeLa cell mtDNA nascent transcripts123, 1227–1240, December 29, 2005 ª2005 Elsevier Inc. 1227
Figure 1. Detection and Precise Mapping of the Two In Vivo HeLa Cell H Strand Transcription Initiation Sites
(A and B) HeLa cell total mtRNA was in vitro labeled with [a-32P]-GTP by guanylyltransferase at the 50 end of the two initiation products of H strand tran-
scription (H1 and H2 transcripts) and analyzed, as detailed in Experimental Procedures, by an S1 nuclease protection assay using an antisense RNA probe.
(A) Schematic representation of the S1 protection assay.
(B) The S1 protection products were analyzed by electrophoresis through an 8% polyacrylamide/7 M urea gel at 300V for 3 hr.
(C and D) A precise mapping, at the nucleotide level, of the 50 ends of the H1 and H2 initiated transcripts in HeLa cell total and poly(A)+ mtRNA samples was
also made by reverse transcriptase (RT) primer extension, carried out in a 0.5% Tween 20 HeLa cell mitochondrial lysate.
(C) A 50-end-labeled primer, complementary to the 12S RNA, with the 50 end corresponding to mtDNA position 728, was used in the presence of AMV
reverse transcriptase. In the schematic drawing, the three kinds of expected extended products are represented.
(D) Samples of total and poly(A)+ mtRNA, the latter obtained as bound RNA by streptavidin-conjugate magnetic beads and biotinylated oligo(dT) primer,
were run through an 8% polyacrylamide/7 M urea sequencing gel. In parallel were run the manual sequencing products obtained by using the fmolR
DNA Cycle Sequencing System (Promega) on the pTER mtDNA clone with the same 50-end-labeled primer which was used for the RT-primer extension.
The H1-initiated transcript has its 50 end at the thymine () at position 561, while the H2 transcript has it at the guanine (*) at position 646, and the 12S RNA,
at the thymine (**) at position 648. Both the H1 and H2 transcripts were of the expected size predicted by the S1 protection experiment (A). M1, ¢X174
DNA/HinfI markers (Promega) 50 end labeled.1228 Cell 123, 1227–1240, December 29, 2005 ª2005 Elsevier Inc.
Figure 2. Stimulation of In Vitro Transcription at the H1 Site Requires Both mTERF and the Termination Site
In vitro labeled mtDNA transcription products, obtained in the presence of increasing amounts of mTERF monomer, were analyzed by S1 nuclease pro-
tection assays.
(A) Quantification by Western blot of the mTERF protein present in the mTERF-enriched fraction (mTERF monomer) and in a whole HeLa cell lysate. The
purified GST-mTERF recombinant fusion protein was used as a standard for quantification purposes.
(B) Comparison of the mTERF amount present in the gel filtration mTERF monomer fraction and in a HeLa cell lysate.
(C) Schematic representation of the S1 protection experiments. Two kinds of templates were used for in vitro transcription, as detailed in Experimental Pro-
cedures: pTER contains the whole mtDNA H strand transcription initiation sequence and also the termination binding sequence for mTERF, while pTER-
EcoRV is a truncated version of pTER, lacking the termination sequence. The run-off transcripts initiated at the H1 site were only observed in vitro.
(D) The products of in vitro transcription and of the S1 nuclease protection assay described in (C) were analyzed in an 8% polyacrylamide/7 M urea gel. The
transcription experiments were carried out with 1 mg of pTER (1.2 pmol; lanes 1–4) or pTER-EcoRV template (1.8 pmol; lanes 5–8), with or without addition of
increasing amounts of mTERF. M2, 50-end-labeled pBR322-MspI DNA markers (New England Biolabs).Cell 123, 1227–1240, December 29, 2005 ª2005 Elsevier Inc. 1229
with [a-32P]-GTP and guanylyltransferase (‘‘capping’’ en-
zyme), followed by an S1 nuclease protection assay and
analysis of the capped products by polyacrylamide/urea
gel electrophoresis (Figures 1A and 1B). Figure 1B shows
the two labeled S1-protected H1 and H2 transcripts. The
second approach involved primer extension by reverse tran-
scriptase (RT-primer extension) using a mitochondrial lysate
(Figures 1C and 1D). In this approach, a 50-end-labeled ap-
propriate H strand oligodeoxynucleotide primer (see Experi-
mental Procedures) was extended by the avian myeloblasto-
sis virus (AMV) reverse transcriptase on the total and poly(A)+
RNA samples up to the 50 end of the three expected tran-
scripts, i.e., the 12S RNA, the H2 nascent transcript, and
the H1 nascent transcript (Figure 1C). The extended primers
were run in a polyacrylamide/urea gel in parallel with the
products of the sequencing reactions of the pTER DNA
clone (Kruse et al., 1989). The two approaches agreed in
confirming the H1 initiation site of rDNA transcription to be
at position 561, 16 bp upstream of the tRNAPhe gene, as pre-
viously established (Figure 1D; Chang and Clayton, 1984).
Furthermore, the results determined for the first time the
precise position of the H2 initiation site to be at nt 646 and
confirmed the 50 end of 12S rRNA to be at nt 648, i.e., two
nucleotides downstream of H2 (Figure 1D).
Isolation and Quantification of mTERF
In the present work, the mTERF monomer-enriched fraction,
isolated by gel filtration chromatography from the S-100
fraction of a HeLa cell mitochondrial lysate (Asin-Cayuela
et al., 2004), was utilized (see Figure S1 in the Supplemental
Data available with this article online) and quantified by West-
ern blot assays using purified recombinant GST (glutathione
S-transferase)-mTERF (see Supplemental Data) as a stan-
dard (Figures 2A and 2B). From the data in Figure 2A, it
was calculated that each HeLa cell contains on the average
6  105 molecules of mTERF.
In Vitro Initiation of Transcription from the H1 Site
Is Stimulated by the mTERF Monomer Only in
Presence of the Termination Site
To understand the role of mTERF in mtDNA H strand tran-
scription initiation at the H1 site, in vitro transcription experi-
ments were carried out using the linearized pTER template
and a truncated version of it lacking the termination binding
site for mTERF, i.e., pTER-EcoRV, in a system utilizing the
mitochondrial lysate (Figure 2C). The products were analyzed
by S1 protection assays using an antisense RNA probe syn-
thesized from the plasmid pKSM2 (Figure 2C). The S1 nucle-
ase protection assays, in experiments using the pTER tem-
plate, revealed that, in the presence of increasing amounts
of mTERF monomer, not only was there termination of
the transcripts at the boundary between the 16S RNA
gene and the tRNALeu(UUR) gene, but also an increase in the
run-off transcripts (Figure 2D, left panel). This result, which
agreed with previous observations (Kruse et al., 1989;
Asin-Cayuela et al., 2004), strongly suggested that the
protein not only acts as a transcription termination factor,
but also stimulates transcription initiation. More surprisingly,1230 Cell 123, 1227–1240, December 29, 2005 ª2005 Elsevier Inexperiments using the pTER-EcoRV template (Figure 2D,
right panel) showed a total lack of stimulation of transcription
by the same levels of mTERF monomer used with the pTER
template, indicating that stimulation of mtDNA H strand tran-
scription initiation by mTERF requires the presence of the H
strand transcription termination site.
Quantitative Termination of Run-Off H1-Initiated
Transcripts Requires a 2-Fold or Greater Molar
Excess of mTERF Over Template
In the experiments of Figure 2D, the pTER template was
in molar excess over mTERF monomer (1.2 pmol versus
0–0.64 pmol). In order to learn what is rate limiting for tran-
scription initiation from the H1 site and for transcription termi-
nation, other experiments of in vitro transcription and S1 nu-
clease protection were carried out, this time using limiting
amounts of pTER template, in the presence of increasing
amounts of mTERF monomer (Figure 3). In these experi-
ments, the level of mTERF monomer varied between 0- and
5-fold the molar amount of the template. As shown in Fig-
ure 3, the frequency of termination of the nascent transcripts
increased with the amount of mTERF monomer, becoming
nearly complete with a 2-fold molar excess and complete
with a 5-fold excess. These experiments indicated that a
significant molar excess of mTERF over the template was
required for quantitative termination of the H1-initiated
transcripts.
mTERF Stimulates Transcription from H1
on rDNA Template by Enhancing the Recycling
of Transcription Machinery
To confirm that the stimulation of H strand transcription initi-
ation by the mTERF monomer is specific for rDNA transcrip-
tion from the H1 site, [a-32P]-GTP-guanylyltransferase cap-
ping experiments were carried out on in vitro synthesized
transcripts. As explained in Experimental Procedures, the
capped in vitro nascent H1 and H2 transcripts shown in Fig-
ure 4 were 30 nucleotides shorter than the in vivo nascent
transcripts shown in Figures 1A and 1B. As illustrated in
the upper panel of Figure 4B (lanes 1–4), the analysis of
the transcripts synthesized on the pTER template in the
presence of increasing amounts of mTERF monomer con-
firmed that the termination factor promotes initiation from
the H1 site without affecting the transcription from the H2
site. Furthermore, in transcription experiments using the
pTER-EcoRV template, no stimulation of initiation from the
H1 site by the mTERF monomer was observed (Figure 4B,
upper panel, lanes 5–8), in agreement with the results shown
in Figure 2D. Interestingly, the addition of the termination
fragment (a 44-mer double-strand oligodeoxynucleotide
corresponding to a mtDNA fragment containing the mTERF
binding site) to transcription reactions using the pTER-
EcoRV template restored partially, up to 30% of the level
observed with the pTER template, the deficient stimulating
effect of mTERF monomer on transcription initiation at the
H1 site observed with the latter template (Figure 4B, upper
panel, lanes 9–11). This result strongly suggested that
the molecular proximity between the H1 initiation andc.
Figure 3. A 2-Fold or Greater Molar Ex-
cess of mTERF over Template Is Essen-
tial for Quantitative Termination of Run-
Off Transcripts
In vitro transcription experiments and S1 nucle-
ase protection assays were carried out, using
a limiting amount of pTER template (0.24 pmol),
in the presence of increasing amounts of mTERF
monomer. The molar ratio of mTERF monomer to
template in the in vitro transcription experiments
varied between 1/3- and 5-fold (lanes 2–6). The
samples where electrophoresed through an 8%
polyacrylamide/7 M urea gel, and the gel was
subsequently analyzed by a PhosporImager. At
the bottom is represented the quantification of the
amounts of run-off and terminated transcripts in
each lane.termination sites may be important to stimulate the H1-
specific transcription by mTERF.
To analyze in detail how mTERF stimulates the H1-specific
transcription, biotinylated transcription template plasmids
immobilized on streptavidin magnetic beads (see Experi-
mental Procedures) were used. This allowed a reduction of
the available amount of transcription machinery, after prein-
cubation of the templates with mitochondrial extract, by
washing out the excess not interacting with the template.
Under the conditions of low concentration of transcription
machinery (including mitochondrial RNA polymerase) thus
achieved, we found that the pTER template still exhibits
the transcription stimulation effect of mTERF (Figure 4B,
lower panel, lanes 1–4). By contrast, the pTER-EcoRV tem-
plate did not show any transcription activation by mTERF,
even after the addition of increasing amounts of mTERF and
termination fragment under the same conditions (Figure 4B,
lower panel, lanes 5–11). More importantly, no transcription
from the H2 site was observed on the pTER template under
conditions of low concentration of transcription machinery
(Figure 4B, lower panel, lanes 1–4). This was in contrast to
the results obtained with the same template not washed
out of the excess amount of transcription machinery (Fig-
ure 4B, upper panel, lanes 1–4). These results suggest thatCell 1the presence of mTERF and the relative proximity between
H1 initiation site and termination site on the same artificial
template stimulate the reinitiation of H1-specific transcription
via repositioning of the transcription machinery without diffu-
sion from template DNA.
To investigate the molecular basis of the H1 site-specific
stimulation of transcription described above, the mtDNA
binding capacity of the mTERF protein was tested. Very in-
terestingly, in electrophoretic mobility shift assays (EMSA),
the interaction of purified recombinant GST-mTERF protein
with the H1 site (contained in a 50-labeled H1 probe [see
Supplemental Data]) was observed (Figure 4C, left panel).
By contrast, the H2 site (contained in a 50-labeled H2 probe)
did not bind to GST-mTERF under the same experimental
conditions (Figure 4C, right panel). This result provided the
important clue that the previously unknown interaction of
mTERF with the H1 site presumably plays a crucial role in
the phenomenon investigated here.
H Strand Transcription Initiation and Termination
Probes Are Band Coshifted with mTERF in EMSA
Experiments
To study the molecular mechanism by which mTERF could
control the rDNA transcription initiation and termination23, 1227–1240, December 29, 2005 ª2005 Elsevier Inc. 1231
Figure 4. mTERF Stimulates Transcription from H1 on rDNA Template by Enhancing the Recycling of Transcription Machinery
(A) As shown in this schematic diagram, transcripts in vitro initiation at the H1 or H2 site were labeled with [a-32P]-GTP and guanylyltransferase and analyzed
by S1 nuclease protection assays (see Experimental Procedures). The DNA templates utilized were pTER and its derivative pTER-EcoRV. The run-off tran-
scripts initiated at the H1 site were only observed in vitro.
(B) mTERF-dependent stimulation of H1 transcription was tested under two different conditions, that is, high (upper panel) and low (lower panel) amount of
mitochondrial transcription machinery (see Experimental Procedures). The experiments with the pTER-EcoRV template were done without (lanes 5–8) or
with the addition of a 44 bp transcription termination fragment (T probe; lanes 9–11). The products of the S1 protection assay were 30 nucleotides shorter
than the products obtained by using in vivo synthesized RNA (Figure 1B), as explained in Experimental Procedures and illustrated in (A). The relative band
intensities of H1 transcripts were quantified by densitometry using the ImageQuant program (Molecular Dynamics). The H1 transcription level of pTER in the
absence of mTERF monomer was set as 100%.
(C) mTERF protein specifically binds to the H1 site. In these DNA mobility shift assays, an increasing amount of recombinant GST-mTERF protein (from 50 to
200 ng) was mixed with 32P-end-labeled H1 or H2 probe (20 fmol each). The sequences of the H1 and H2 probes correspond to the human mtDNA L-strand
nt 524–576 and nt 601–660, respectively. The purified recombinant GST-mTERF showed interaction with the H1 site (left panel), whereas the H2 site was
not bound under these conditions (right panel). C, protein-DNA complex; F, free probe.activities, EMSA experiments were performed using an infra-
red laser scanning system (Odyssey, LiCor), as previously
described (see Experimental Procedures). Figure 5 shows
the results of EMSA experiments with the mTERF monomer-
enriched fraction and the T probe (green fluorescence), en-
compassing the termination binding site, and the I probe
(red fluorescence), which contains the H strand transcription
initiation sites (see Experimental Procedures). The mTERF
monomer fraction showed a specific binding activity for the
I probe (Figure 5A, lanes 2–4) and T probe (Figure 5A, lanes1232 Cell 123, 1227–1240, December 29, 2005 ª2005 Elsevier In6–8). The shifted bands were in each case specifically
super-shifted (Figure 5A, lanes 3 and 7) by the addition of
mTERF antiserum to the binding reaction mixture, whereas
no super-shift was observed in the controls with preimmune
serum (Figure 5A, lanes 4 and 8). The most important re-
sult was the presence of a band coshifted with the two
DNA probes (Figure 5A, lanes 10–12), which also was specif-
ically super-shifted by mTERF antiserum (Figure 5A, lane 11).
This result points to a simultaneous interaction of mTERF
(or mTERF plus some auxiliary protein[s] present in thec.
Figure 5. Transcription Initiation and Termination Probes
Are Band Coshifted with mTERF
EMSA experiments with two different fluorescent DNA probes to test the
mTERF binding sites for transcription initiation (I probe, red fluorescence)
and for transcription termination (T probe, green fluorescence) were per-
formed as described in Experimental Procedures.
(A) The specific binding activity of mTERF for the I probe (lanes 1–4) and
the T probe (lanes 5–8) and its simultaneous binding interaction with the
two DNA probes (lanes 9–12), as indicated by the yellow merged cosh-
ifted band. Lanes 3, 7, and 11 represent super-shift experiments after
the addition of mTERF-antiserum, and lanes 4, 8, and 12 the correspond-
ing controls with a preimmune serum. FI, free I probe, and FT, free T
probe; S, shifted bands of the single probe binding test (lanes 2, 4, 6,
and 8); SS, super-shifted bands of the single-probe bindings; CS, cosh-
ifted bands with the two probes; SCS, super-shift band of the CS. A con-
trol for nonspecific binding activity for other mtDNA sequences was done
by using a 75-fold molar excess of a 100 bp unlabeled probe representing
a fragment of the COXII gene (lane 13).
(B) Competition experiments for the I probe (lanes 1–3) and the T probe
(lanes 4–6) binding activities using a 50-molar excess of the correspond-
ing unlabeled probes.Cemonomer fraction) with the initiation and termination sites.
A 75-fold molar excess of a fragment of the cytochrome c ox-
idase subunit II gene (COXII) was used to exclude the occur-
rence of nonspecific interactions of the mTERF fraction with
mtDNA sequences (Figure 5A, lane 13). Figure 5B shows
that the binding of mTERF to each of the two DNA fluorescent
probes is competed for completely by a 50-fold molar excess
of the same unlabeled probe.
Interestingly, the mTERF comigration with the initiation
and termination sites shown above was not detected with
the recombinant mTERF protein. In fact, with the latter pro-
tein, a high concentration (100-fold molar excess) of unla-
beled initiation fragment (H1, not H2) only partially competed
with the 32P-labeled termination fragment (TERM) and did
not show the comigration (Figure S2, left panel). In contrast,
with the recombinant mTERF protein, the unlabeled termina-
tion probe (TERM) competed effectively with the 32P-labeled
TERM (Figure S2, right panel). These results clearly show
that the capacities of natural mTERF and recombinant
mTERF for binding to both sites are different.
Molecular Analysis of the Band-Coshifted
Complexes
To analyze the molecular nature of the coshifted complexes,
a differential membrane transfer system (Demczuk et al.,
1993) was used after the EMSA experiments. In these, the
band-coshifted complexes were obtained using the same
amounts of I probe and T probe and increasing amounts of
mTERF (Figure 6A). In the same gel, different amounts of
the two free DNA probes were loaded to construct standard
curves (see Experimental Procedures). After electrophoresis,
the protein and the two DNA probes were blotted onto
two different membranes simultaneously. The nitrocellulose
membrane used for the mTERF immunoblot (Figure 6B, left
panel) shows the mTERF present in the coshifted complexes.
By using the mTERF standard curve (Figure 6B, right panels),
the amount of mTERF in these complexes could be esti-
mated. Figure 6C (left panel) shows the two-wavelength infra-
red scanning of the nylon membrane used to transfer the
DNA from the EMSA gel (Figure 6A), which gives a pattern
identical to that of the gel. Figure 6C (central panels) shows
the single wavelength scan image of the nylon membrane
for each of the two DNA probes. The two probes are cosh-
ifted to give the yellow coshifted complex band in the merging
image of the two-wavelength scans. Within a red or green
contour are shown the samples for the standard curve of
I-probe or T-probe, respectively. The DNA standard curves
were in a very good linear range (Figure 6C, right panels). In
the three coshifted complexes obtained with increasing
amounts of mTERF monomer, the molar amounts of mTERF
and the I probe were very similar, whereas the amounts of the
T probe were 30%–50% higher (table in Figure 6C).
In Vivo Association of mTERF with the H1 Initiation
and Termination Sites of H Strand Transcription
Revealed by Chromatin Immunoprecipitation
To test the prediction that the mTERF protein should be as-
sociated with the H1 initiation sequence in vivo, the H1ll 123, 1227–1240, December 29, 2005 ª2005 Elsevier Inc. 1233
Figure 6. Molecular Analysis of the Band-Coshifted Complexes
Band-coshifted complexes were electroblotted onto a selective two-membrane-transfer system to analyze the relative molar amounts of I probe, T probe,
and protein in the ternary complexes, as detailed in Experimental Procedures.
(A) Infrared fluorescence image of the EMSA gel prior to the electrotransfer, showing the two overlaid fluorescent channel scans of the coshifted complexes
produced by incubating the two DNA probes with increasing amounts of mTERF monomer (lanes 1–3). The right side of the panel shows increasing
amounts of free I probe or T probe loaded on the gel to construct standard curves for the DNA quantification described below in (C). FI, free I probe;
FT, free T probe; CS, band-coshifted complex.
(B) Quantification of the mTERF present in the coshifted complex. The protein was transferred to a nitrocellulose membrane and analyzed by Western blot-
ting using mTERF antiserum. The left subpanel shows the immunoblots of the band-coshifted complexes (CS) presented in (A) (lanes 1–3), which agree
perfectly with the CS positions. For the quantification of mTERF in each lane, a standard curve with increasing amounts of the mTERF monomer fraction
(filled blue circles) was constructed (right subpanels). The filled red squares represent the estimated amounts of mTERF monomer.
(C) Quantification and relative molar amount calculation of the coshifted DNA I and T probes. In the same two-membrane-transfer system described above,
the nylon membrane, carrying the free DNA probes and the coshifted DNA probes, was analyzed by the infrared laser scanning system (Odyssey, LiCor).
The left panel shows the two overlaid fluorescent channel scans of the nylon membrane, with the coshifted complexes produced in the presence of increas-
ing amounts of mTERF monomer (lanes 1–3), as described in (A), and also the two fluorescence patterns obtained with increasing amounts of the free1234 Cell 123, 1227–1240, December 29, 2005 ª2005 Elsevier Inc.
initiation site was analyzed by the chromatin immunoprecip-
itation technique (ChIP; Orlando, 2000), using affinity-purified
mTERF antibody (Figure 7A; Experimental Procedures). As
a positive control, the in vivo interaction between mTERF
and the transcription termination site was analyzed by using
the same antibody and preimmune serum as a negative con-
trol. To detect mTERF-dependent immunoprecipitation of
mtDNA fragments, specific primer sets (Table S1) were de-
signed for amplification of several segments of mtDNA
(Figure 7A). The amplification of every immunoprecipitated
mtDNA segment was performed in the linear range, and the
molecular abundances were quantified by densitometry of
ethidium bromide-stained bands (Figures 7B and 7C). As ex-
pected, the transcription termination site and initiation site
were immunoprecipitated and amplified comparably by the
mTERF-specific antibody. By contrast, the amplification of
other portions of the mitochondrial genome revealed a very
weak or no signal above background (Figure 7B). Thus, the
above described results showed that there is a good correla-
tion between the in vivo ChIP results and results of the EMSA
assays in which mTERF was tested against the H1 or H2 ini-
tiation site (Figure 4C).
Measurement of Affinities of mTERF for the H1
Initiation and Termination Sites
To measure the affinities of mTERF for the two mtDNA bind-
ing sites, the apparent equilibrium dissociation constants
(KD’s) of mTERF for the two sites were determined by carry-
ing out several independent EMSAs. Thus, the purified in vivo
generated mTERF was shown to have very similar affinities to
the termination and H1 sites (KD values of 50 ± 2.5 nM and
62 ± 5.7 nM, respectively). This was in agreement with the
finding that mTERF can bind simultaneously to the two sites,
as shown in Figures 5 and 6. The latter data are perfectly
consistent with the results of our ChIP experiments. By con-
trast, by using the recombinant human GST-mTERF protein
expressed in a soluble form in E. coli, we ascertained the av-
erage KD values (±SEM) for the termination and H1 sites to
be 65 ± 1.2 nM and 750 ± 9.7 nM, respectively.
Mitochondrial rDNA Looping in the In Vitro
Transcription Template Detected by Electron
Microscopy (EM)
The results described above support a simultaneous interac-
tion of mTERF with its two mtDNA binding sites. A plausible
mechanism for this interaction may be a looping out of the
rDNA. Figure 7D represents a schematic model of this
mTERF-mediated rDNA loop. In this model, the binding of
mTERF to its binding sites, presumably together with auxil-
iary transcription factors such as TFAM (Fisher and Clayton,
1988) and/or TFB1M or TFB2M (Falkenberg et al., 2002),Cell 1specifically drives the RNA polymerase to the H1 initiation
site. The loop structure might provide a mechanism to acti-
vate a new rDNA transcription event after the completion
of the previous one.
To determine directly if protein-mediated rDNA looping
occurs between the H1 and termination mTERF binding
sites, the linearized 1.3 Kb pTER DNA template was incu-
bated with a mitochondrial lysate from HeLa cells and the
mTERF monomer protein (see Experimental Procedures).
Following incubation, the protein was fixed with glutaralde-
hyde, free protein was removed by gel filtration chromatog-
raphy, and the reaction products examined by EM. Examina-
tion of fields of molecules revealed four classes of DNA
molecules: protein-free DNA, DNA with a single protein com-
plex bound internally along its length, DNA with two distinct
protein complexes bound internally (Figure 7E), and DNA
with a large loop (representing roughly 1/3 of the total length)
bound to a protein complex at its base (Figure 7F). The posi-
tions of the bound protein complexes were consistent with
the location of the mTERF binding sites (Tables S2 and
S3). There were also some DNA molecules with protein
bound to one or both ends. The amounts of internal single
binding or double binding protein complexes and the loop
formation increased almost regularly with the amount of ex-
ogenous mTERF up to a certain saturating protein concen-
tration (data not shown).
In Vivo Detection of Mitochondrial rDNA Looping
by Chromosome Conformation Capturing Assay
We also demonstrated the mTERF-mediated rDNA loop for-
mation in vivo by a chromosome conformation capturing (3C)
assay, carried out as described (Dekker et al., 2002), with
some modifications. A description of the detailed method
used is available in Supplemental Data. The basic principle
of this technique was that intact cells were treated with 1%
formaldehyde to crosslink mTERF and portions of mtDNA
which were in close proximity to each other (Figure 7G, upper
panel). The crosslinked mtDNA-protein complex was di-
gested with the restriction enzyme HpyCH4IV, and the
mTERF-mediated DNA-protein complex was isolated by im-
munoprecipitation using affinity-purified mTERF antibody.
The mTERF-crosslinked mtDNA fragments were then ligated
at very low DNA concentrations that favor intramolecular in-
teraction, rather than random intermolecular interactions. Af-
ter ligation, the crosslinks were reversed by overnight heating
and treatment with proteinase K. The ligation products were
then analyzed by PCR using two different pairs of primers (a
and b or a and c in Figure 7G). The expected sizes of PCR
products obtained using the a + b primer set and the a + c
primer set were 661 bp and 1043 bp, respectively. We also
used other mtDNA samples prepared under differentprobes. The two central panels show the single wavelength fluorescence channel images of the membrane observed for the I probe (700 nm channel)
and T probe (800 nm channel). The three single-color bands in the upper portion of each panel are exactly at the same positions in the image, representing
the coshifted complexes. The right panels show the points of the standard curve for each probe indicated by filled blue circles, and the estimated values for
the band-coshifted DNA amounts indicated by filled red squares. The table represents the molar amounts of mTERF monomer, I and T probe in the band-
coshifted complexes (CS), as well as the approximate estimated relative molar amounts of mTERF, I, and T probe in each of the three complexes.23, 1227–1240, December 29, 2005 ª2005 Elsevier Inc. 1235
Figure 7. ThemTERF Protein Interacts with the Initiation and Termination Sites ofMitochondrial rDNA Transcription andMediates
rDNA Looping In Vivo and In Vitro
(A) Map of target sites for PCR-mediated detection of the mtDNA fragments crosslinked to mTERF using the ChIP technique. The numbers in brackets
indicate the positions of the PCR products in the Cambridge human mtDNA sequence (Anderson et al., 1981). TERM, mitochondrial rDNA transcription
termination site; rRNAJ, junction between 12S rRNA and 16S rRNA genes; H1, mitochondrial rDNA transcription initiation site; LSP, light-strand promoter;
COXII, cytochrome c oxidase subunit II gene; L, tRNALeu(UUR); V, tRNAVal; F, tRNAPhe.1236 Cell 123, 1227–1240, December 29, 2005 ª2005 Elsevier Inc.
conditions, without the crosslinking or ligation step, as con-
trol templates. Representative agarose gel electrophoresis
runs of PCR products obtained under the different conditions
are shown in Figure 7G (lower panel). The production of PCR
products of the right sizes was fully dependent on the cross-
linking and ligation steps. Furthermore, the ligation-depen-
dent generation of a new HpyCH4IV enzyme cut at the ex-
pected position in each PCR product was fully confirmed
by redigestion with the same enzyme (Figure S3).
DISCUSSION
This work has provided strong evidence indicating that the
mechanism underlying the regulation of human mitochon-
drial rDNA transcription by mTERF involves the simultaneous
interaction of this factor with the initiation and termination
sites and the resulting looping-out of the rDNA. In fact, the
observation that, in in vitro transcription experiments, the
stimulation of rDNA H strand transcription from the H1 site
by the mTERF monomer did not occur if the artificial template
lacked the mTERF termination binding site suggested that
the transcription stimulating activity requires the mTERF
monomers to be bound to the termination site. In the case
of the truncated template (pTER-EcoRV), the stimulation
of rDNA transcription by mTERF could be restored up to
30% of the level observed with the full-length template
(pTER) after addition of a 44-mer termination fragment to the
reaction mixture, however, only in the presence of a high
concentration of the mitochondrial transcription machinery.
It is possible that mTERF has another stimulatory role,
maybe by bending the DNA to an easy-to-initiate confor-
mation or working as an enhancer effector that requires
that mTERF DNA binding domains are bound to both DNA
sites to have an active conformation. It should also be men-
tioned that, in previous reports, the stimulation effect by
mTERF was not observed in an in vitro transcription system
using template DNA containing a nonnatural promoter (such
as LSP, SP6, or T7 promoter) and a nonnatural starting site
(Hess et al., 1991; Prieto-Martı´n et al., 2004).
In the present work, a simultaneous binding of the natural
mTERF monomer to the I probe and T probe was shownCell 1clearly in a series of EMSA experiments using infrared fluo-
rescence measurements and following Western blot analy-
sis. The I probe used in the present work included both the
H1 and the H2 sites. However, other evidence indicated
that mTERF did bind to and stimulated transcription from
a mtDNA fragment encompassing only the H1 site, but not
from a fragment carrying only the H2 site (Figure 4C). A quan-
tification of the infrared fluorescence measurement and
Western blot data showed the presence in the coshifted
bands, produced from a nearly equimolar mixture of the
three components, of average relative molar amounts of
1, 1, and 1.3–1.5 for mTERF monomer, I probe, and
T probe, respectively.
That the capacity of mTERF monomer to interact in vitro
with the two mtDNA fragments carrying the H1 initiation
site or the termination site reflected an in vivo phenomenon
was shown by in vivo ChIP assays, in which the simulta-
neous binding of mTERF to the two mtDNA sites occurred
with two separated mtDNA segments in vivo. A very likely
mechanism for this process, strongly supported by direct
electron microscopy (EM) would involve a looping-out of
the rDNA. The in vivo occurrence of an mTERF-mediated
rDNA loop formation was fully confirmed by a chromosome
conformation capturing assay (Figure 7G). The looping
mechanism could explain the 15- to 60-fold higher rate
of rRNA synthesis over mRNA synthesis in vivo (Montoya
et al., 1983) as resulting from the enhancement of the reini-
tiation rate of the H1-specific transcription event. The 2-fold
or greater molar excess of mTERF monomer over the artifi-
cial mtDNA template, which was required, in the in vitro tran-
scription experiments, for quantitative termination of H1-
initiated transcripts, may, at least in part, account for the
large excess (>70 fold) of mTERF molecules per cell deter-
mined in this work (6  105) over the amount of mtDNA
per cell (7–8  103 [King and Attardi, 1989]) in HeLa cells.
This high concentration of mTERF maintained in vivo may
ensure a stable rDNA loop structure between the H1 initia-
tion and the termination sites for each ‘‘coupled’’ rDNA tran-
scription event.
It is possible that a single mTERF molecule binds to the ter-
mination site and to the H1 site of the same mtDNA molecule(B) The relative amounts of the PCR products were compared after electrophoresis in a 1% agarose gel and EtBr staining. The PCR reactions of the products
immunoprecipitated by preimmune serum and of the mitochondrial lysate input were used as negative and positive control, respectively. Only the mtDNA
fragments containing the termination site (TERM) or initiation site (H1) of rDNA transcription could be amplified by their specific PCR primer sets. The input
was 10% of the total mtDNA fragment pool used for immunoprecipitation.
(C) DNA fragments detected by PCR with primer sets for TERM, rRNAJ, H1, LSP, and COXII in HeLa cell mtDNA crosslinked and immunoprecipitated with
purified anti-mTERF antibody. The mtDNA fragments containing the transcription termination site (TERM) or initiation site (H1) were immunoprecipitated and
amplified comparably by the mTERF-specific antibody. Each bar represents the average of three independent experiments, and the SEM is indicated.
(D) Schematic representation of a proposed model for an mTERF-mediated rDNA loop structure. H1 (red fragment), rDNA transcription initiation and mTERF
binding site; H2, total H strand transcription initiation site; TERM (green fragment), rDNA transcription termination and mTERF binding site. RNA Pol, human
mtRNA polymerase; TFAM, human mitochondrial transcription factor A; TFBM, human mitochondrial transcription factors B1 and/or B2.
(E) EM image of a pTER DNA molecule with two bound protein complexes situated at the two mTERF binding sites, according to measurements of DNA
lengths and positions of the bound protein complexes.
(F) EM image of a looped pTER DNA molecule. The sizes of the loop, long arm, and short arm in (E) and (F) are consistent with the protein-mediated looping
occurring via the mTERF binding sites.
(G) In vivo interaction between the H1 site and the termination site, as detected by 3C assays. The upper panel shows the experimental scheme, the ori-
entation of the primers (small arrows), and the location of the HpyCH4IV sites near the H1 (red) site and the termination (green) site. The mTERF or mTERF-
mediated structure was represented as a blue oval. The lower panel shows the PCR products derived from primer combinations after ligation between the
HpyCH4IV fragments harboring the H1 site and the termination site. The primer combinations are shown above the gel.23, 1227–1240, December 29, 2005 ª2005 Elsevier Inc. 1237
at the same time. Another possibility is that one mTERF mol-
ecule binds to each site of the same mtDNA molecule and
that the two mTERF molecules then interact with each other,
either directly or with the intermediary of one or more mTERF
molecules, possibly with the participation of auxiliary pro-
teins. However, the available results, and in particular the
competition EMSA data, do not allow yet a decision about
which of the models mentioned above operates in vivo.
Very recently, evidence has been reported that a re-
combinant rat mitochondrial transcription termination factor
exhibited a binding activity for the mitochondrial promoter re-
gion (Prieto-Martı´n et al., 2004). In the above cited work, no
evidence was found of the simultaneous formation of a
complex of this rat mTERF with the termination probe and
the promoter probe. However, the estimated KD values for
the termination and H1 sites of a rat His-mTERF were
210 nM and1300 nM, respectively, which are reasonably
close to those estimated in the present work for the recombi-
nant human GST-mTERF protein expressed in E. coli (65 nM
and 750 nM, respectively). This observation points to the
possible role of the recombinant nature of mTERF in produc-
ing the difference in its affinity for the two sites, possibly as a
result of differences in secondary modifications. In the pres-
ent work, we have in fact demonstrated that there is a clear
discrepancy between purified in vivo and in vitro generated
human mTERF in their DNA binding properties, with the
H1 binding affinity of purified in vivo generated mTERF being
quite higher than that of recombinant mTERF. It is a reason-
able idea that the natural mTERF protein may have a post-
translational modification(s) or a binding cofactor(s) which in-
creases its affinity for the H1 site.
In the present work, no analysis of the mTERF domains(s)
interacting with the T probe and the I probe was carried out.
However, the observation that the stoichiometry of binding in
the ternary complex approximated 1:1:1 favors the conclu-
sion that mTERF has two binding sites, one specific for the
H1 promoter and the other for the terminator. This conclu-
sion strongly supports the interpretation that regulation of
human mitochondrial rRNA synthesis involves an mTERF-
mediated rDNA looping. A role of DNA loops in control of
gene expression has also been described in yeast. Thus, in
a recent paper (O’Sullivan et al., 2004), findings are reported
that illustrate the role of gene loops in juxtaposed promoters
and terminators in S. cerevisiae.
Our work has revealed a quite novel mechanism for acti-
vating mitochondrial rRNA synthesis in mammalian cells.
This mechanism involves, first, the specific selection of the
mitochondrial rDNA transcription initiation site H1 between
the two well-documented H strand initiation sites and then
an mTERF-mediated molecular process that facilitates the
recycling of mitochondrial RNA polymerase on the same
rDNA loop-forming template mtDNA molecule.
EXPERIMENTAL PROCEDURES
HeLa Cell Mitochondrial RNA Extraction and Fractionation
The mitochondrial fraction was prepared by differential centrifugation
(Kruse et al., 1995) from 3–4  109 cells, purified by Percoll/Metrizamide1238 Cell 123, 1227–1240, December 29, 2005 ª2005 Elsevier Ingradient centrifugation (Storrie and Madden, 1990; Helm and Attardi,
2004), and then incubated with micrococcal nuclease (Sigma) and, sub-
sequently, with 100 mg/ml of proteinase K (Roche) for 30 min at 37ºC
(Attardi and Montoya, 1983). RNA was finally extracted using the RNA-
bee system (Tel-Test, Inc.). The separation of poly(A)+RNA (bound RNA)
and non-poly(A)+RNA from 0.5 mg of total mitochondrial RNA was ob-
tained using a PolyATract mRNA isolation system (Promega).
In Vitro Transcription of mtDNA with Different Templates
In vitro transcription, using [a-32P]-UTP in the 13,000 gav supernatant of
a 0.5% Tween 20 mitochondrial lysate, was performed essentially as de-
scribed (Kruse et al., 1995; Ferna´ndez-Silva et al., 1996; Asin-Cayuela
et al., 2004). Two mtDNA templates were used (Figure 2C). One template
was the human mtDNA clone pTER (Kruse et al., 1989) and the other,
pTER-EcoRV (Figure 2C), was a derivative of pTER lacking the termination
site, which was obtained by cutting it with EcoRV (New England Biolabs).
Partial Purification and Quantification of mTERF
The mTERF monomer-enriched fraction used in the present work was ob-
tained by gel filtration chromatography of the S-100 fraction from a HeLa
cell mitochondrial lysate, as described (Asin-Cayuela et al., 2004; Fig-
ure S1). The amount of mTERF in a single HeLa S3 cell or mTERF mono-
mer fraction was determined by Western blot analysis, using a standard
curve from various known amounts of the recombinant GST-mTERF,
as described in Supplemental Data.
S1 Nuclease Protection Assay
The guanylyltransferase + [a-32P]-GTP capping reaction specifically
labels nascent transcripts which carry a di- or triphosphate nucleotide
at their 50 end. In vivo or in vitro synthesized mtRNA was labeled with gua-
nylyltransferase and [a-32P]-GTP following the procedure described by
Kruse et al. (1995). After the capping reaction, the samples were analyzed
by the S1 nuclease protection assay. For this purpose, [a-32P]-GTP-
labeled RNA samples were hybridized with the antisense RNA probe de-
scribed in Supplemental Data (synthesized from the plasmid pGEHP23
with SP6 RNA polymerase), digested with S1 nuclease, and the capped
products were analyzed by 8% polyacrylamide/7M urea gel electrophore-
sis (Figures 1A and 1B), as detailed elsewhere (Ferna´ndez-Silva et al.,
1996).
For the in vitro-transcribed RNA, the bands resolved by urea-polyacryl-
amide gel electrophoresis in the S1 protection assays were 30 nucleoti-
des shorter (Figure 4) than those obtained with in vivo synthesized RNA
(Figures 1A and 1B). This was expected, since the 12S RNA gene frag-
ment inserted into the artificial DNA templates pTER and pTER-EcoRV,
utilized for in vitro transcription, starts at nucleotide 648 and ends at
nucleotide position 739, and the antisense RNA probe utilized in the S1
nuclease protection assays encompasses a fragment of mtDNA from
position 524 to position 768.
For a transcription reinitiation assay at a low concentration of transcrip-
tion machinery, including the mitochondrial RNA polymerase, template
plasmids immobilized on magnetic beads were used. The pTER plasmids
were cut with HindIII, and biotin-14-dATP was then incorporated into the
HindIII site using the Klenow enzyme. The biotinylated plasmids were cut
with EcoRI or EcoRV and then purified by 1% agarose gel electrophoresis.
Biotinylated templates (10 mg) were bound to 500 ml of streptavidin mag-
netic beads (Dynal) and incubated with 2% bovine serum albumin (BSA)
to block nonspecific binding sites. The immobilized template plasmids
were incubated with 2.5 ml of the S100 fraction of a mitochondrial lysate
diluted with transcription buffer (10 mM Tris-HCl [pH 8.0; 25ºC], 10 mM
MgCl2, 1 mM DTT, 100 mg/ml BSA, 10% glycerol) without NTPs at 30ºC
for 15 min and washed once with the same buffer. Transcription was
started by addition of 25 ml of transcription buffer containing 0.6 mM of
each NTP and different amounts of purified natural mTERF and T probe
and incubation at 30ºC for 30 min. The nascent transcripts were detected
by in vitro capping and the S1 nuclease protection assay described above.
In the in vitro transcription experiments in which the transcribed mtRNA
was labeled with [a-32P]-UTP (Figures 2D and 3), the samples were alsoc.
analyzed by the S1 protection assay (Ferna´ndez-Silva et al., 1996), utiliz-
ing the other unlabeled antisense RNA probe described in Supplemental
Data (synthesized from the pKSM2 plasmid with T3 RNA polymerase).
50 End Mapping of In Vivo-Initiated Transcripts
In order to obtain a precise mapping of the 50 ends of the mtDNA H strand
nascent transcripts (H1 and H2 transcripts), purified total mtRNA and pol-
yadenylated mtRNA from HeLa cells synthesized in vivo were analyzed by
reverse transcription-primer extension (RT-primer extension; Calzone
et al., 1987; Boorstein and Craig, 1989). For this purpose, a 50-end-
labeled oligodeoxynucleotide primer, complementary to a portion of the
12S RNA sequence (corresponding to the mtDNA segment between
nucleotides 708 and 728; Figure 1C), and AMV reverse transcriptase
(Promega) were utilized. The L strand primer sequence was: 50-(728) gag
ggtgaactcactggaacg (708)-3
0. After the RT-primer extension, 20 ml of
urea loading dye was added to each sample, and the samples were
heated at 90ºC for 10 min, and either loaded directly onto an 8% poly-
acrylamide/7 M urea gel and run in parallel with the pTER manual se-
quencing products described below or stored at 20ºC.
The manual sequencing analysis of the pTER clone was carried out by
the fmolR DNA Cycle Sequencing System (Promega), according to the
manufacturer’s instructions, using the same 50-end-labeled primer de-
scribed above for the RT-primer extension.
EMSA by a Two-Fluorescence Infrared Imaging System
A two-fluorescence infrared laser scanning system (Odyssey, LiCor) was
used in the EMSA assays aimed at analyzing the double interaction of
mTERF with the termination and initiation binding sites. The termination
probe (T probe) and initiation probe (I probe) were prepared as described
in Supplemental Data. The Odyssey system enables the simultaneous
visualization of two molecules differently labeled with the IRDye 800 and
IRDye 700. The standard band-shift assay reaction mixture was as previ-
ously described (Asin-Cayuela et al., 2004). The incubation was carried
out at 4ºC for 20 min, and immediately the samples were loaded onto
a native 8% polyacrylamide gel in Tris/glycine/EDTA buffer in the cold
room. Supershift experiments were carried out by including 2 ml of anti-
mTERF antiserum in the reaction, and controls were performed with
2 ml of preimmune serum.
We measured the apparent equilibrium dissociation constants (KD’s ±
SE) of human mTERF for the DNA binding sites by using three indepen-
dent EMSAs to estimate the amounts of the bound and unbound probes.
The protocols in detail are available in Supplemental Data.
Selective-Membrane Transfer of the DNA Probes and mTERF
from Band-Coshifted Complexes
The molecular analysis of the protein-DNA coshifted complexes was
made, after the EMSA gel run and subsequent scanning (Figure 6A), by us-
ing a system of double membrane electroblotting (Demczuk et al., 1993),
with some modifications, as detailed in Supplemental Data. The electro-
blotted membranes were analyzed by Western blotting or Odyssey infra-
red fluorescence laser system (LiCor), as described in Supplemental Data.
Chromatin Immunoprecipitation Technique and Chromosome
Conformation Capturing Assay
ChIP experiments were carried using a technique based on a combination
and modifications of previously described protocols (Orlando, 2000 and
references therein). Sequences of mtDNA subregion-specific primers
and a description of the detailed method used are available in Supple-
mental Data. A description of the procedure followed for the chromatin
conformation capturing assay can also be found in Supplemental Data.
Preparation of DNA-Protein Complexes for EM
A 25 ml reaction mixture containing 150 ng of the linearized 1.3 kb pTER
DNA template was incubated for 30 min at 30ºC in transcription buffer
(Ferna´ndez-Silva et al., 1996), supplemented with 1.3 ml of mitochondrial
lysate and mTERF monomer protein (3–25 ng). The reaction mixture was
fixed, fractionated by gel filtration chromatography, and the fractions con-Cell 1taining the DNA-protein complexes were prepared for EM as described
(Griffith and Christiansen 1978).
The samples were examined in a Philips/FEI Tecnai 12 TEM at 40 KV,
and the images were recorded using a Gatan Ultrascan US4000P slow
scan CCD camera (Gatan). DNA lengths were measured using GATAN
Digital Micrograph 3.0 software.
Supplemental Data
Supplemental Data include three figures, three tables, and Supplemental
Experimental Procedures and can be found with this article online at
http://www.cell.com/cgi/content/full/123/7/1227/DC1/.
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